ArticlePsychopharmacology2026
Suicide attempt risk among patients receiving methylphenidate: a retrospective cohort study.
Article in Psychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMethylphenidate may reduce suicide risk among patients with attention-deficit hyperactivity disorder. Several studies have noted that the association between methylphenidate use and suicidality is weakening.
methodsData were collected from Taiwan's National Health Insurance Research Database to assess the association between methylphenidate exposure and suicide attempt risk across two exposure periods (main analysis: 2001-2002; duplication analysis: 2004-2005). We compared suicide attempt risk between patients who initiated methylphenidate treatment and those with no recorded psychiatric treatment or methylphenidate exposure during the same period.
resultsIn both the main and duplication analyses, patients receiving methylphenidate exhibited a higher subsequent risk of suicide attempts than unexposed individuals. A duration-response pattern was observed in both cohorts: the hazard ratio of suicide attempts declined with longer cumulative methylphenidate use, from 1.60/1.84 for < 30 days to 1.45/1.65 for ≥ 180 days. Because hazard ratios were closely aligned across 2001-2002 and 2004-2005, the association of methylphenidate with reduced suicide attempt risk did not appear to decrease over time. DISCUSSION: Longer use of methylphenidate was associated with a lower risk of subsequent suicide attempts among patients in Taiwan receiving methylphenidate. The beneficial effect of methylphenidate on suicide risk remained consistent over time.
Indexed as
Identifiers
42384171What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.